Reported implantable ports|deltec specialty epidural ports described and event of idursulfase being infused intrathecal for eight years when failure occurred.This medication was being given for therapy to a (b)(6) year old male diagnosed with huntington syndrome along with epilepsy since (b)(6) 2018.The event described failure of the intrathecal catheter being dislodged from the reservoir proximal and uncertain position distally.Then described intervention of abdominal xray was taken along with other testing of cfs fluid.Chest x ray was describing the tip at approximately the level of t -2 spine of the thoracic level.Then on (b)(6) 2021 the issue of device failure was reported to be resolved.Product may have caused or contributed to serious injury.No additional adverse patient effects.Device revealed it had expired when it was in usage.
|